Characterization of Aspergillus fumigatus specific CD4 T cell responses.

烟曲霉特异性 CD4 T 细胞反应的表征。

基本信息

  • 批准号:
    7014796
  • 负责人:
  • 金额:
    $ 46.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-01 至 2011-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Aspergillus fumigatus is a spore forming mold that causes a range of human diseases, including allergic bronchopulmonary aspergillosis, an asthma-like disease, and invasive aspergillosis, a frequently fatal infection that occurs in immunocompromised individuals. Infection by Aspergillus fumigatus results from inhalation of fungal spores (referred to as conidia), which are taken up by alveolar macrophages and killed by products of the oxidative burst. Although A. fumigatus-specific T lymphocytes are postulated to play a role in both allergic and invasive aspergillosis, very little is known about their activation, proliferation, differentiation and persistence following inhalation of fungal spores. To address this issue, we made CD4 T cell hybridomas specific for A. fumigatus antigens, cloned the alpha and beta chains of the specific T cell receptor and generated T cell receptor transgenic mice. Experiments proposed in this grant application will use T cell receptor transgenic mice to obtain naive, A. fumigatus-specific T cells for transfer and characterization in infected recipient mice. We have three specific aims. The first is to investigate priming and differentiation of naive A. fumigatus-specific T lymphocytes following pulmonary infection with live conidia. The impact of IL10 and TGF-beta signaling on T cell proliferation and differentiation will be determined. The second aim is to determine the impact of A. fumigatus-specific CD4 T cells on invasive fungal disease in immunocompromised or bone marrow transplanted mice. Our third aim is to investigate innate immune responses to fungal spores and to determine the impact of this process on the differentiation of A. fumigatus-specific CD4 T cells. We will initially focus on MyD88, Trif and Rip2 mediated signals. These studies will provide a comprehensive picture of T cell responses to the most prevalent opportunistic fungal pathogen of humans, potentially opening the door to new therapeutic interventions to combat allergic and invasive fungal diseases.
描述(由申请人提供):烟曲霉是一种孢子形成霉菌,可导致一系列人类疾病,包括过敏性支气管肺曲霉菌病,一种哮喘样疾病,以及侵袭性曲霉病,一种经常发生在免疫功能低下的人身上的致命感染。感染烟曲霉菌的原因是吸入了真菌孢子(称为分生孢子),分生孢子被肺泡巨噬细胞摄取,并被氧化爆发的产物杀死。尽管烟曲霉菌特异性T淋巴细胞在过敏性和侵袭性曲霉病中都起作用,但对其在吸入真菌孢子后的激活、增殖、分化和持久性了解甚少。为了解决这个问题,我们制作了针对烟曲霉菌抗原的CD4T细胞杂交瘤,克隆了特异性T细胞受体的α链和β链,并产生了T细胞受体转基因小鼠。在这项拨款申请中提出的实验将使用T细胞受体转基因小鼠来获得幼稚的、烟曲霉菌特异的T细胞,用于在受感染的小鼠中转移和鉴定。我们有三个具体目标。第一个是研究活孢子肺部感染后幼稚烟曲霉菌特异性T淋巴细胞的启动和分化。IL-10和转化生长因子-β信号对T细胞增殖和分化的影响将被确定。第二个目的是确定烟曲霉特异的CD4T细胞对免疫受损或骨髓移植小鼠侵袭性真菌疾病的影响。我们的第三个目标是研究对真菌孢子的先天免疫反应,并确定这一过程对烟曲霉特异性CD4T细胞分化的影响。我们将首先关注MyD88、Trif和RIP2介导的信号。这些研究将提供T细胞对人类最普遍的机会性真菌病原体的反应的全面图景,可能为对抗过敏性和侵袭性真菌疾病的新的治疗干预打开大门。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric G. Pamer其他文献

Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli
布氏罗得西亚锥虫半胱氨酸蛋白酶在大肠杆菌中的表达及缺失分析
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Eric G. Pamer;C. Davis;Magdalene So
  • 通讯作者:
    Magdalene So
Gut microbes fend off harmful bacteria by depriving them of nutrients
肠道微生物通过剥夺有害细菌的营养物质来抵御它们。
  • DOI:
    10.1038/d41586-024-02803-w
  • 发表时间:
    2024-09-18
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Eric G. Pamer
  • 通讯作者:
    Eric G. Pamer
Protection against emClostridioides difficile/em disease by a naturally avirulent strain
天然无毒菌株对艰难梭菌疾病的保护作用
  • DOI:
    10.1016/j.chom.2024.11.003
  • 发表时间:
    2025-01-08
  • 期刊:
  • 影响因子:
    18.700
  • 作者:
    Qiwen Dong;Stephen Harper;Emma McSpadden;Sophie S. Son;Marie-Maude Allen;Huaiying Lin;Rita C. Smith;Carolyn Metcalfe;Victoria Burgo;Che Woodson;Anitha Sundararajan;Amber Rose;Mary McMillin;David Moran;Jessica Little;Michael W. Mullowney;Ashley M. Sidebottom;Louis-Charles Fortier;Aimee Shen;Eric G. Pamer
  • 通讯作者:
    Eric G. Pamer
Immune Responses to <em>Aspergillus fumigatus</em> Infections
  • DOI:
    10.1016/j.bbmt.2005.09.007
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Amariliz Rivera;Tobias Hohl;Eric G. Pamer
  • 通讯作者:
    Eric G. Pamer
A spoonful of sugar could be the medicine
一勺糖可能就是良药
  • DOI:
    10.1038/nature23084
  • 发表时间:
    2017-06-14
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Hea-Jin Jung;Eric G. Pamer
  • 通讯作者:
    Eric G. Pamer

Eric G. Pamer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric G. Pamer', 18)}}的其他基金

CACHET - Environmental Biomarkers Core
CACHET - 环境生物标志物核心
  • 批准号:
    10641975
  • 财政年份:
    2017
  • 资助金额:
    $ 46.2万
  • 项目类别:
CACHET - Environmental Biomarkers Core
CACHET - 环境生物标志物核心
  • 批准号:
    10394644
  • 财政年份:
    2017
  • 资助金额:
    $ 46.2万
  • 项目类别:
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
  • 批准号:
    9922844
  • 财政年份:
    2016
  • 资助金额:
    $ 46.2万
  • 项目类别:
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
  • 批准号:
    9108539
  • 财政年份:
    2016
  • 资助金额:
    $ 46.2万
  • 项目类别:
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
  • 批准号:
    9234463
  • 财政年份:
    2016
  • 资助金额:
    $ 46.2万
  • 项目类别:
Innate immune defense against clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
  • 批准号:
    9175987
  • 财政年份:
    2012
  • 资助金额:
    $ 46.2万
  • 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
  • 批准号:
    8871670
  • 财政年份:
    2012
  • 资助金额:
    $ 46.2万
  • 项目类别:
Innate immune defense against clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
  • 批准号:
    10055905
  • 财政年份:
    2012
  • 资助金额:
    $ 46.2万
  • 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
  • 批准号:
    8369912
  • 财政年份:
    2012
  • 资助金额:
    $ 46.2万
  • 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
  • 批准号:
    8495909
  • 财政年份:
    2012
  • 资助金额:
    $ 46.2万
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 46.2万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 46.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 46.2万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 46.2万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 46.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 46.2万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 46.2万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 46.2万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 46.2万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 46.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了